Nadroparin Medication Information
Discover comprehensive details about Nadroparin, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.
The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.
Additionally, explore the Nadroparin brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.
Generic Name : Nadroparin Pronunciation : na-droe-PARE-in ICD Code : Y44.2 Therapeutic Classification : Anticoagulants / AntithromboticsBrand Names or Trade Names of Nadroparin
India :
Nadrohep 2850 IU |
Cardioparin |
Cardioparin (0.6 ml) |
Fraxiparine (0.8 ml) |
Fraxiparine |
Fraxiparine (0.3ml) |
Nadroparin |
Cardioparin (10 ml) |
Fraxiparine (0.6ml) |
Nadroparin (3800 iu)
International :
Fraxiparine, Fraxiparine Forte
Why is Nadroparin Prescribed? (Indications)
This medication is a low molecular weight heparin, prescribed for venous thromboembolism, pulmonary embolism and unstable angina.When should Nadroparin not be taken? (Contraindications)
Contraindicated in patients with history of abnormal decrease in platelet counts, uncontrolled high blood pressure, increased risk of bleeding, peptic ulceration, head injuries, stroke. It should not be administered by the IM route.What is the dosage of Nadroparin?
Unstable Angina: Adults: The dose is based on body weight. It is usually 86 anti-factor Xa International Units (IU) per kilogram (kg) (39.1 anti-factor Xa IU per pound) of body weight injected under the skin every twelve hours for six days.Venous thromboembolism and Pulmonary Embolism:
Adults: The dose is usually 2850 anti-factor Xa IU injected under the skin once a day beginning two to four hours before surgery and continuing for at least seven days.
How should Nadroparin be taken?
It comes as a solution for injection, to be administered by a healthcare provider under the skin.What are the warnings and precautions for Nadroparin?
• Caution should be exercised in patients undergoing epidural anesthesia, history of heparin-induced platelet defects, increased risk of bleeding, severe liver or kidney disease, any allergy, during pregnancy and breastfeeding.• Monitor signs of bleeding and potassium level in blood.
